Research programme: P 014 - NB Health Laboratory
Alternative Names: P-014 - NB Health LaboratoryLatest Information Update: 28 Oct 2025
At a glance
- Originator NB Health Laboratory
- Class Anti-inflammatories; Antivirals; Monoclonal antibodies
- Mechanism of Action G protein-coupled receptor antagonists
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Gastrointestinal disorders; Viral infections
Most Recent Events
- 28 Oct 2025 No recent reports of development identified for research development in Gastrointestinal-disorders in Japan (Parenteral)
- 28 Oct 2025 No recent reports of development identified for research development in Viral-infections in Japan (Parenteral)
- 28 Sep 2021 P 014 - NB Health Laboratory is available for licensing as of 28 Sep 2021. https://nbhl.co.jp/nbhlhpwordpress/partnering.html